SQI Diagnostics One-hour coronavirus triage test developed by SQI Diagnostics to receive funding from University Health Network . Volume building > might be looking for a run here
0%
0%
0%
0%
0%
−0.050CAD
−18.523MCAD
8.102MCAD
101.842M
About SQI DIAGNOSTICS INC
Sector
Industry
CEO
Andrew Morris
Website
Headquarters
Toronto
Founded
1999
ISIN
CA78466B1085
SQI Diagnostics, Inc. engages in developing and selling testing kits, services, and automated testing systems to clinical laboratories, hospitals, clinicians, and diagnostic testing companies. It operates through the following segments: Development of Organ Health Diagnostic Tests; COVID-19-Related Diagnostics Tests; Direct-to-Consumer Tests for Celiac and Rheumatoid Arthritis Diseases; and Distribution of Existing COVID-19 Polymerase Chain Reaction and Antigen Tests. The company was founded by Peter Lea in 1999 and is headquartered in Toronto, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
